Company Overview and News

 
CDL Integrated Sustainability Report 2018: On Track To Achieve Sustainability Goals Amid Increased Regulations, Green Consumerism And Investment

2018-05-02 accesswire
SINGAPORE / ACCESSWIRE / May 2, 2018 / City Developments Limited (CDL) (FRA: CDE) has published its latest Integrated Sustainability Report 2018: On Track To CDL Future Value 2030. The report shows CDL's progress towards the material Environmental, Social and Governance (ESG) goals and targets under its CDL Future Value 2030 sustainability blueprint. Against the backdrop of increased regulations and demand for sustainable products and investments, the future-fit blueprint drives CDL's integrated sustainability strategy towards 2030, a milestone year for global climate agreement and sustainable development.

1
Singapore home prices rise fastest in almost 8 years in the first quarter

2018-04-02 scmp
The island state’s housing market is recovering from a 4-year; price rise boosted by pent-up demand and stronger economic growth

 
Property stocks decline following higher buyer's stamp duty - Channel NewsAsia

2018-02-20 channelnewsasia
SINGAPORE: Property-related stocks saw a decline on Tuesday (Feb 20), a day after the Government announced in the Budget speech that the Buyer’s Stamp Duty (BSD) would be raised.

 
ASX ends flat after late surge

2018-02-20 smh.com.au
Australian shares managed to claw back from early losses to end the day barely changed, as banks came under a bit of selling pressure but earnings and broker moves helped limit downside.

 
Singapore property stocks fall on higher home purchase tax

2018-02-20 themalaymailonline
Stamp duty on the portion of a property’s price above S$1 million will be raised effective immediately, to 4 per cent from 3 per cent, the government said in its budget on Monday. — Reuters picSINGAPORE, Feb 20 — Singapore property stocks declined after the government raised taxes on home purchases of more than S$1 million (RM2.9 million), just as the housing market starts to recover from a four-year slump.

 
Singapore Budget 2018: Winners and losers

2018-02-19 themalaymailonline
Singapore Budget 2018 aims to financially equip the city state for financial pressures that will come with a rapidly aging population. — Reuters file pic SINGAPORE, Feb 19 — A range of tax increases, including a 2 percentage point increase to 9 per cent in the goods and services levy, were unveiled by Singapore Finance Minister Heng Swee Keat in his budget speech to Parliament as among measures to financially equip the city state for financial pressures that will come with a rapidly aging population.

 
Singapore property stocks show ‘fatigue’ with surge in enblocs

2018-02-19 themalaymailonline
Collective apartment sales in the first two months of 2018 totalled over S$3.1 billion (RM9.1 billion), almost twice the S$1.66 billion seen in the last peak of the enbloc market in 2007. — TODAY picSINGAPORE, Feb 19 — A spate of enbloc sales, coupled with a rebound in the property market at the start of the year, may indicate that Singapore developers will be more cautious in adding to landbanks and about their pricing strategies, analysts say.

 
Dispute over property defects at The Sail resolved out of court - Channel NewsAsia

2018-02-09 channelnewsasia
SINGAPORE: Residents of The Sail @ Marina Bay have resolved a long-running dispute with the luxury condominium's developer Glengary and contractor Dragages Singapore over what they claim are property defects.

 
DBS, CDL among firms recognised for gender-equality efforts on Bloomberg index - Channel NewsAsia

2018-01-23 channelnewsasia
SINGAPORE: Two Singaporean firms, DBS Bank and City Developments Limited (CDL), were among 104 recognised for their gender-equality efforts in the 2018 Bloomberg Gender-Equality Index launched on Monday (Jan 22). 

 
'Long Winter' Seen Ending for Singapore Home Prices: Survey - Bloomberg

2018-01-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Listed developer CDL sued over property defects - Channel NewsAsia

2018-01-18 channelnewsasia
SINGAPORE: For almost eight years, residents at The Sail @ Marina Bay had to bear with the stench from the rubbish chutes of their million-dollar homes.

 
Singapore Property Rebound Just Starting as Prices Seen Jumping - Bloomberg

2018-01-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Singapore property seen on path to recovery after prolonged slump

2018-01-10 themalaymailonline
Real estate services firm Colliers today said average home prices may rise by 17 per cent over 2018-2021. — TODAY picSINGAPORE, January 10 — Singapore’s housing market is expected to build on its recovery over 2018, analysts say, as private home prices marked their first annual rise in four years.

 
Singapore authorities' housing market warning may fall on deaf ears

2017-12-22 in.reuters
SINGAPORE (Reuters) - Singapore’s authorities are concerned the island-state’s property market could be setting itself up for a fall.

 
'Stars are aligned' for Singapore stocks to go higher in 2018: Analysts - Channel NewsAsia

2017-12-17 channelnewsasia
SINGAPORE: The likes of banking heavyweights, developers and property trusts will continue to lead the charge next year for Singapore’s stock market, which could see gains of as much as 11 per cent, according to market analysts.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...

CUSIP: 006197928